The theory is that more frequent exposure might maintain steadier blood levels throughout the day
Home blood pressure monitoring, if available, provides valuable data between appointments and empowers patients to participate actively in their care
Some patients respond extremely well to semaglutide, while others experience stronger appetite control with tirzepatide
The standard titration schedule begins at 2.5 mg weekly for four weeks, then increases to 5 mg weekly, with further increases in 2.5 mg increments every four weeks as tolerated, up to a maximum of 15 mg weekly
The dose-escalation schedule for Wegovy is fixed: Weeks 1-4: 0.25 mg subcutaneously once weekly Weeks 5-8: 0.5 mg once weekly Weeks 9-12: 1.0 mg once weekly Weeks 13-16: 1.7 mg once weekly Week 17 onward: 2.4 mg once weekly (maintenance) GI side effects, including nausea, vomiting, and the delayed gastric emptying that complicates ibuprofen use, are most intense during dose escalation
However, these reports are not uniform
